Latest reported quarter: ANNUAL, ended Dec 2025 · reported in EUR
This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.
| Line item | 2026 Q2 (EUR) |
|---|---|
| Total Assets | €253.72M |
| Total Liabilities | €71.30M |
| Goodwill and Other Intangible Assets | €841,000.00 |
| Investments and Advances | €1.28M |
| -Gross PPE | €71.51M |
| Net PPE | €71.51M |
| Total Non-Current Assets | €73.63M |
| Other Current Assets | €15.27M |
| Inventory | €25.45M |
| -Other Receivables | €8.29M |
| -Accounts Receivable | €12.20M |
| Receivables | €20.49M |
| -Short Term Investments | €5.46M |
| -Cash and Cash Equivalents | €113.42M |
| Cash and Cash Equivalents & Short-Term Investments | €118.88M |
| Total Current Assets | €180.09M |
| Total Current Liabilities | €57.82M |
| Payables | €7.76M |
| -Accounts Payable | €7.76M |
| Gains/Losses Not Affecting Retained Earnings | €489.48M |
| Retained Earnings | -€307.14M |
| -Common Stock | €80,000.00 |
| Capital Stock | €80,000.00 |
| Stockholders' Equity | €182.42M |
| Total Equity | €182.42M |
| Employee Benefits | €14,000.00 |
| -Long Term Capital Lease Obligation | €11.31M |
| -Long Term Debt | €2.16M |
| Short-Term Debt and Capital Lease Obligation | €15.15M |
| -Current Debt | €12.81M |
| -Current Capital Lease Obligation | €2.34M |
| Current Deferred Liabilities | €13.80M |
| Other Current Liabilities | €12.15M |
| Total Non-Current Liabilities | €13.48M |
| Long Term Debt and Capital Lease Obligation | €13.47M |
| Line item | 2025 ANNUAL (EUR) |
2024 ANNUAL (EUR) |
|---|---|---|
| -Less:Write Off | €182,000.00 | -€19,000.00 |
| Pretax Profit | -€54.06M | -€54.10M |
| Tax | €333,000.00 | €2,000.00 |
| Net Profit | -€54.39M | -€54.11M |
| Profit from Continuing Operations | -€54.39M | -€54.11M |
| Net Income to Parent Company | -€54.39M | -€54.11M |
| Net Income to Common Stockholders | -€54.39M | -€54.11M |
| Basic EPS | -€1.78 | -€1.77 |
| Diluted EPS | -€1.78 | -€1.77 |
| -General & Admin Expense | €18.48M | €12.40M |
| -Less:Other Special Charges | -€213,000.00 | – |
| -Less:Impairment of Capital Assets | €1.78M | €0.00 |
| Special Income (Charges) | -€1.75M | €19,000.00 |
| Total Revenue as Reported | €31.33M | €16.44M |
| Total Operating Revenue | €31.33M | €16.44M |
| Cost of Revenue | €16.35M | €11.35M |
| Gross Profit | €14.98M | €5.08M |
| Operating Expense | €71.30M | €55.14M |
| Selling and Admin Expenses | €24.35M | €16.85M |
| -Selling & Marketing Expense | €5.88M | €4.45M |
| Research & Development | €50.68M | €42.42M |
| Other Operating Expenses | -€3.73M | -€4.13M |
| Gain on Sale of Security | -€148,000.00 | €34,000.00 |
| Other Income (Expense) | -€1.90M | €53,000.00 |
| Total Other Finance Costs | -€3.38M | €2.60M |
| Non-Operating Interest Expense | €1.13M | €1.52M |
| Non-Operating Interest Income | €1.91M | €15,000.00 |
| Net Non-Operating Interest Income (Expense) | €4.16M | -€4.10M |
| Operating Profit | -€56.32M | -€50.06M |
No comments yet — be the first to weigh in on IQMX.